Rheumatic And Autoimmune Diseases
Celebrating the life of Philip C. Robinson, MBChB, PhD, FRACP
The rheumatology community recently lost physician and educator Philip Robinson, MBChB, PhD, FRACP, associate professor in the faculty of medicine at the Royal Brisbane Clinical Unit at the University of Queensland, in Australia.
EULAR: Workplace support, inclusivity imperative for patients with RMDs
For patients with rheumatic and musculoskeletal diseases to maintain healthy work lives, it is essential for workplaces to offer healthy and supportive attitudes and environments, according to new EULAR points to consider.
‘Can’t be in 10 places at once’: Social media now a key part of rheumatology meetings
COVID-19 was in so many ways an inflection point for nearly all aspects of health care, with one of the most conspicuous, continuing examples of “pre-2020” differing from “post-2020” being the way people consume data from meetings.
CATCR-T cell therapy may aid in antiphospholipid syndrome through selective B-cell depletion
PHILADELPHIA — Upcoming T-cell therapies may treat antiphospholipid syndrome and other autoimmune diseases without compromising a patient’s defenses against infection, according to data presented at ACR Convergence 2022.
Unvaccinated pregnant patients with RMDs, COVID-19 at higher risk for preterm birth
PHILADELPHIA — Preterm birth is more frequent among unvaccinated pregnant patients with rheumatic and musculoskeletal diseases and COVID-19 vs. fully vaccinated patients, according to findings presented at ACR Convergence 2022.
Understanding of long COVID shifting at ‘breakneck speed’
PHILADELPHIA — The understanding of long COVID, its symptoms and even its definition, continues to rapidly change amid a flood of data, according to Leonard H. Calabrese, DO, and Alfred Kim, MD, PhD, at ACR Convergence 2022.
Evusheld impactful at reducing COVID-19 infections, improving outcomes
PHILADELPHIA — COVID-19 infections in patients who receive tixagevimab/cilgavimab are “infrequent,” and “mild in severity,” according to early data presented at ACR Convergence 2022.
‘Stigma’ surrounding opioids, pain management harms patients, feeds biases
SAN DIEGO — The stigma surrounding opioid use and pain management continues to significantly impact patient care in rheumatology today, according to a presentation at the Congress of Clinical Rheumatology West.
Immunologic strategies for antiphospholipid syndrome still yield ’not great results’
SAN DIEGO — Primary prevention remains the biggest treatment challenge in antiphospholipid syndrome, according to a speaker at the Congress of Clinical Rheumatology West.
Cognitive dysfunction more common ‘than we want to admit’ in rheumatic disease
SAN DIEGO — Limited assessment tools make it difficult to determine the prevalence and severity of cognitive disorders in patients with rheumatic and autoimmune diseases, according to a speaker at the Congress of Clinical Rheumatology West.